These reports summarise the surveillance of influenza, COVID-19 and other seasonal respiratory illnesses in England.
Weekly findings from community, primary care, secondary care and mortality surveillance systems are included in the reports.
This page includes reports published from 18 July 2024 to the present.
Please note that after the week 21 report (covering data up to week 20), this surveillance report will move to a condensed summer report and will be released every 2 weeks.
Previous reports on influenza surveillance are also available for:
View previous COVID-19 surveillance reports.
View the pre-release access list for these reports.
Our statistical practice is regulated by the Office for Statistics Regulation (OSR). The OSR sets the standards of trustworthiness, quality and value in the https://code.statisticsauthority.gov.uk/" class="govuk-link">Code of Practice for Statistics that all producers of Official Statistics should adhere to.
In early-February 2020, the first cases of COVID-19 in the United Kingdom (UK) were confirmed. As of December 2023, the South East had the highest number of confirmed first episode cases of the virus in the UK with 3,180,101 registered cases, while London had 2,947,727 confirmed first-time cases. Overall, there has been 24,243,393 confirmed cases of COVID-19 in the UK as of January 13, 2023.
COVID deaths in the UK COVID-19 was responsible for 202,157 deaths in the UK as of January 13, 2023, and the UK had the highest death toll from coronavirus in western Europe. The incidence of deaths in the UK was 297.8 per 100,000 population as January 13, 2023.
Current infection rate in Europe The infection rate in the UK was 43.3 cases per 100,000 population in the last seven days as of March 13, 2023. Austria had the highest rate at 224 cases per 100,000 in the last week.
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
These reports summarise the surveillance of influenza, COVID-19 and other seasonal respiratory illnesses.
Weekly findings from community, primary care, secondary care and mortality surveillance systems are included in the reports.
This page includes reports published from 14 July 2022 to 6 July 2023.
Previous reports on influenza surveillance are also available for:
View previous COVID-19 surveillance reports.
The HM Prison and Probation Service (HMPPS) COVID-19 statistics provides monthly data on the HMPPS response to COVID-19. It addresses confirmed cases of the virus in prisons and the Youth Custody Service sites, deaths of those individuals in the care of HMPPS and mitigating action being taken to limit the spread of the virus and save lives.
Data includes:
Deaths where prisoners, children in custody or supervised individuals have died having tested positive for COVID-19 or where there was a clinical assessment that COVID-19 was a contributory factor in their death.
Confirmed COVID-19 cases in prisoners and children in custody (i.e. positive tests).
Narrative on capacity management data for prisons.
The bulletin was produced and handled by the ministry’s analytical professionals and production staff. For the bulletin pre-release access of up to 24 hours is granted to the following persons:
Lord Chancellor and Secretary of State for Justice; Minister of State for Prisons and Probation; Permanent Secretary; Private Secretaries (x6); Deputy Director of Data and Evidence as a Service and Head of Profession, Statistics; Director General for Policy and Strategy Group; Deputy Director Joint COVID 19 Strategic Policy Unit; Head of News; Deputy Head of News and relevant press officers (x2)
Chief Executive Officer; Private Secretary - Chief Executive Officer; Director General Operations; Director General Chief Executive Officer; Deputy Director of COVID-19 HMPPS Response; Deputy Director Joint COVID 19 Strategic Policy Unit
Prison estate expanded to protect NHS from coronavirus risk
Measures announced to protect NHS from coronavirus risk in prisons
As of May 2, 2023, the outbreak of the coronavirus disease (COVID-19) had been confirmed in almost every country in the world. The virus had infected over 687 million people worldwide, and the number of deaths had reached almost 6.87 million. The most severely affected countries include the U.S., India, and Brazil.
COVID-19: background information COVID-19 is a novel coronavirus that had not previously been identified in humans. The first case was detected in the Hubei province of China at the end of December 2019. The virus is highly transmissible and coughing and sneezing are the most common forms of transmission, which is similar to the outbreak of the SARS coronavirus that began in 2002 and was thought to have spread via cough and sneeze droplets expelled into the air by infected persons.
Naming the coronavirus disease Coronaviruses are a group of viruses that can be transmitted between animals and people, causing illnesses that may range from the common cold to more severe respiratory syndromes. In February 2020, the International Committee on Taxonomy of Viruses and the World Health Organization announced official names for both the virus and the disease it causes: SARS-CoV-2 and COVID-19, respectively. The name of the disease is derived from the words corona, virus, and disease, while the number 19 represents the year that it emerged.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Self-reported COVID-19 infections and other respiratory illnesses, including associated symptoms and health outcomes. Joint study with the UK Health Security Agency. These are official statistics in development.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Number of deaths registered each month in England and Wales, including deaths involving the coronavirus (COVID-19), by age, sex and country.
The following dashboards provide data on contagious respiratory viruses, including acute respiratory diseases, COVID-19, influenza (flu), and respiratory syncytial virus (RSV) in Massachusetts. The data presented here can help track trends in respiratory disease and vaccination activity across Massachusetts.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Daily Coronavirus (Covid-19) positive tests in Leicester City Council and surrounding districts.Data for the most recent 4-5 days is likely to be incomplete.Please note automatic updates to this dataset were discontinued on 12th December 2023.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
This open data publication has moved to COVID-19 Statistical Data in Scotland (from 02/11/2022) Novel coronavirus (COVID-19) is a new strain of coronavirus first identified in Wuhan, China. Clinical presentation may range from mild-to-moderate illness to pneumonia or severe acute respiratory infection. This dataset provides information on demographic characteristics (age, sex, deprivation) of confirmed novel coronavirus (COVID-19) cases, as well as trend data regarding the wider impact of the virus on the healthcare system. Data includes information on primary care out of hours consultations, respiratory calls made to NHS24, contact with COVID-19 Hubs and Assessment Centres, incidents received by Scottish Ambulance Services (SAS), as well as COVID-19 related hospital admissions and admissions to ICU (Intensive Care Unit). Further data on the wider impact of the COVID-19 response, focusing on hospital admissions, unscheduled care and volume of calls to NHS24, is available on the COVID-19 Wider Impact Dashboard. There is a large amount of data being regularly published regarding COVID-19 (for example, Coronavirus in Scotland - Scottish Government and Deaths involving coronavirus in Scotland - National Records of Scotland. Additional data sources relating to this topic area are provided in the Links section of the Metadata below. Information on COVID-19, including stay at home advice for people who are self-isolating and their households, can be found on NHS Inform. All publications and supporting material to this topic area can be found in the weekly COVID-19 Statistical Report. The date of the next release can be found on our list of forthcoming publications. Data visualisation is available to view in the interactive dashboard accompanying the COVID-19 Statistical Report. Please note information on COVID-19 in children and young people of educational age, education staff and educational settings is presented in a new COVID-19 Education Surveillance dataset going forward.
Based on a comparison of coronavirus deaths in 210 countries relative to their population, Peru had the most losses to COVID-19 up until July 13, 2022. As of the same date, the virus had infected over 557.8 million people worldwide, and the number of deaths had totaled more than 6.3 million. Note, however, that COVID-19 test rates can vary per country. Additionally, big differences show up between countries when combining the number of deaths against confirmed COVID-19 cases. The source seemingly does not differentiate between "the Wuhan strain" (2019-nCOV) of COVID-19, "the Kent mutation" (B.1.1.7) that appeared in the UK in late 2020, the 2021 Delta variant (B.1.617.2) from India or the Omicron variant (B.1.1.529) from South Africa.
The difficulties of death figures
This table aims to provide a complete picture on the topic, but it very much relies on data that has become more difficult to compare. As the coronavirus pandemic developed across the world, countries already used different methods to count fatalities, and they sometimes changed them during the course of the pandemic. On April 16, for example, the Chinese city of Wuhan added a 50 percent increase in their death figures to account for community deaths. These deaths occurred outside of hospitals and went unaccounted for so far. The state of New York did something similar two days before, revising their figures with 3,700 new deaths as they started to include “assumed” coronavirus victims. The United Kingdom started counting deaths in care homes and private households on April 29, adjusting their number with about 5,000 new deaths (which were corrected lowered again by the same amount on August 18). This makes an already difficult comparison even more difficult. Belgium, for example, counts suspected coronavirus deaths in their figures, whereas other countries have not done that (yet). This means two things. First, it could have a big impact on both current as well as future figures. On April 16 already, UK health experts stated that if their numbers were corrected for community deaths like in Wuhan, the UK number would change from 205 to “above 300”. This is exactly what happened two weeks later. Second, it is difficult to pinpoint exactly which countries already have “revised” numbers (like Belgium, Wuhan or New York) and which ones do not. One work-around could be to look at (freely accessible) timelines that track the reported daily increase of deaths in certain countries. Several of these are available on our platform, such as for Belgium, Italy and Sweden. A sudden large increase might be an indicator that the domestic sources changed their methodology.
Where are these numbers coming from?
The numbers shown here were collected by Johns Hopkins University, a source that manually checks the data with domestic health authorities. For the majority of countries, this is from national authorities. In some cases, like China, the United States, Canada or Australia, city reports or other various state authorities were consulted. In this statistic, these separately reported numbers were put together. For more information or other freely accessible content, please visit our dedicated Facts and Figures page.
As of January 12, 2023, COVID-19 has been responsible for 202,157 deaths in the UK overall. The North West of England has been the most affected area in terms of deaths at 28,116, followed by the South East of England with 26,221 coronavirus deaths. Furthermore, there have been 22,264 mortalities in London as a result of COVID-19.
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
https://www.ons.gov.uk/aboutus/whatwedo/statistics/requestingstatistics/approvedresearcherschemehttps://www.ons.gov.uk/aboutus/whatwedo/statistics/requestingstatistics/approvedresearcherscheme
The purpose of this dataset is to understand the prevalence of the coronavirus in the UK population, using longitudinal data and including not only cross-sectional data but the inclusion of an antibody test for a sub-sample of people. Demographic information is also included allowing for analyse by different variables to identify patterns and trends.
Participants have three options open to them; can have just have one visit, can have a visit every week for a month or, can have a visit every week for a month and then continue to have visits every month for one year in total from when you joined the study. This is entirely voluntary.
At each visit a field worker conducts a questionnaire, and supervises swab tests. A proportion of visits also include a blood sample being taken. The swab and blood samples are tested at laboratories.
The overall purpose of this study is to understand how many people across the UK have or may already have had the coronavirus. This will help the government manage the pandemic moving forwards.
The COVID-19 Community Infection Survey includes information on: • how many people across England and Wales (extending to Scotland and Northern Ireland) test positive for COVID-19 at a given point in time, regardless of whether they report experiencing symptoms • the average number of new infections per week over the course of the study • the number of people who test positive for antibodies, to indicate how many people are ever likely to have had the virus • key demographic information (sex, age, occupation)
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Age-standardised mortality rates for deaths involving coronavirus (COVID-19), non-COVID-19 deaths and all deaths by vaccination status, broken down by age group.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Provisional deaths registration data for single year of age and average age of death (median and mean) of persons whose death involved coronavirus (COVID-19), England and Wales. Includes deaths due to COVID-19 and breakdowns by sex.
As of November 24, 2024 there were over 274 million confirmed cases of coronavirus (COVID-19) across the whole of Europe since the first confirmed cases in France in January 2020. France has been the worst affected country in Europe with 39,028,437 confirmed cases, followed by Germany with 38,437,756 cases. Italy and the UK have approximately 26.8 million and 25 million cases respectively. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.
As global communities responded to COVID-19, we heard from public health officials that the same type of aggregated, anonymized insights we use in products such as Google Maps would be helpful as they made critical decisions to combat COVID-19. These Community Mobility Reports aimed to provide insights into what changed in response to policies aimed at combating COVID-19. The reports charted movement trends over time by geography, across different categories of places such as retail and recreation, groceries and pharmacies, parks, transit stations, workplaces, and residential.
https://www.cogconsortium.uk/data/https://www.cogconsortium.uk/data/
The current COVID-19 pandemic, caused by the SARS-CoV-2 virus, represents a major threat to health in the UK and globally. To fully understand the transmission and evolution of the virus requires sequencing and analysing viral genomes at scale and speed. The numbers of samples calls for a rapid increase in the UK’s pathogen genome sequencing capacity rapidly and robustly.
To provide this increased capacity to collect, sequence and analyse the whole genomes of virus samples in the UK, the COVID-19 Genomics UK (COG-UK) consortium is pooling the world leading knowledge and expertise in genomics of the four UK Public Health Agencies, multiple regional University hubs, and large sequencing centres such as the Wellcome Sanger Institute.
https://www.ucl.ac.uk/health-informatics/research/vivaldi-study/vivaldi-privacy-noticehttps://www.ucl.ac.uk/health-informatics/research/vivaldi-study/vivaldi-privacy-notice
The study will be expanding to other providers and care homes across England and will provide a detailed picture of prevalence, seroprevalence, transmission and potential immunity over time.By testing around 6500 staff and 5000 residents across >100 care homes in England, we will estimate the proportion who have been infected with COVID-19 in the past and have antibodies, and the proportion who are infected now. These tests will be repeated over time to learn how COVID-19 spreads in care homes and how long the antibody response lasts and whether this helps to prevent re-infection with the virus. In those who are currently infected, we will also collect information on who is experiencing symptoms to help us to understand how this affects spread of infection within care homes. We will find out about how infection spreads between care homes, the community and hospitals by linking the information we collect to national data on hospital admissions and deaths.
N.B.: The data within the VIVALDI 2 dataset is being examined and cleaned to improve its quality, this is ongoing work.
A survey carried out in the United Kingdom in September 2021 revealed that the main source used for news on COVID-19 among consumers aged 16 to 24 years old was the BBC, with 51 percent saying that they went to a BBC platform for coronavirus updates in the last week. The same share of respondents in that age group also used social media for COVID-19 information, whereas older consumers were more likely to read newspapers.
For further information about the coronavirus (COVID-19) pandemic, please visit our dedicated Facts and Figures page.
These reports summarise the surveillance of influenza, COVID-19 and other seasonal respiratory illnesses in England.
Weekly findings from community, primary care, secondary care and mortality surveillance systems are included in the reports.
This page includes reports published from 18 July 2024 to the present.
Please note that after the week 21 report (covering data up to week 20), this surveillance report will move to a condensed summer report and will be released every 2 weeks.
Previous reports on influenza surveillance are also available for:
View previous COVID-19 surveillance reports.
View the pre-release access list for these reports.
Our statistical practice is regulated by the Office for Statistics Regulation (OSR). The OSR sets the standards of trustworthiness, quality and value in the https://code.statisticsauthority.gov.uk/" class="govuk-link">Code of Practice for Statistics that all producers of Official Statistics should adhere to.